Center for Cellular Immunotherapies logo` Center for Cellular Immunotherapies

Payne Lab

Publications

  1. Cho MJ, Lo ASY, Mao X, Nagler AR, Ellebrecht CT, Mukherjee EM, Hammers CM, Choi EJ, Sharma PM, Uduman M, Li H, Rux AH, Farber SA, Rubin CB, Kleinstein SH, Sachais BS, Posner MR, Cavacini LA, Payne AS. (2014) Shared VH1-46 gene usage by pemphigus vulgaris autoantibodies indicates common humoral immune responses among patients. Nat Commun. 5: 4167. PMC4120239.
  2. Hammers CM, Chen J, Lin C, Kacir S, Siegel DL, Payne AS, Stanley JR. (2015) Persistence of anti-desmoglein 3 IgG+ B-cell clones in pemphigus patients over years. J Invest Dermatol. 135: 742-49. PMC4294994.
  3. Ellebrecht CT, Bhoj VG, Nace A, Choi EJ, Mao X, Cho MJ, Di Zenzo G, Lanzavecchia A, Seykora JT, Cotsarelis G, Milone MC, Payne AS. (2016) Reengineering chimeric antigen receptor T cells for targeted therapy of autoimmune disease. Science. 353: 179-84. PMC5343513.
  4. Cho MJ, Ellebrecht CT, Hammers CM, Mukherjee EM, Sapparapu G, Boudreaux CE, McDonald SM, Crowe JE, Jr., Payne AS. (2016) Determinants of VH1-46 cross-reactivity to pemphigus vulgaris autoantigen desmoglein 3 and rotavirus antigen VP6. J Immunol. 197: 1065-73. PMC4976025.
  5. Chen J, Zheng Q, Hammers CM, Ellebrecht CT, Mukherjee EM, Tang HY, Lin C, Yuan H, Pan M, Langenhan J, Komorowski L, Siegel DL, Payne AS, Stanley JR. (2017) Proteomic analysis of pemphigus autoantibodies indicates a larger, more diverse, and more dynamic repertoire than determined by B cell genetics. Cell Rep. 18: 237-47. PMC5221611.
  6. Mao X, Cho MJ, Ellebrecht CT, Mukherjee EM, Payne AS. (2017) Stat3 regulates desmoglein 3 transcription in epithelial keratinocytes. JCI Insight. 2: e92253. PMC5414550.
  7. Ellebrecht CT, Mukherjee EM, Zheng Q, Choi EJ, Reddy SG, Mao X, Payne AS. (2018) Autoreactive IgG and IgA B cells evolve through distinct subclass switch pathways in the autoimmune disease pemphigus vulgaris. Cell Rep. 24: 2370-80. PMC6156788.
  8. Cho A, Caldara AL, Ran NA, Menne Z, Kauffman RC, Affer M, Llovet A, Norwood C, Scanlan A, Mantus G, Bradley B, Zimmer S, Schmidt T, Hertl M, Payne AS, Feldman R, Kowalczyk AP, Wrammert J. (2019) Single-cell analysis suggests that ongoing affinity maturation drives the emergence of pemphigus vulgaris autoimmune disease. Cell Rep. 28:909-22.e6. PMC6684256.
  9. Kushner CJ, Wang S, Tovanabutra N, Tsai DE, Werth VP, Payne AS. (2019) Factors associated with complete remission after rituximab therapy for pemphigus. JAMA Dermatol. doi: 10.1001/jamadermatol.2019.3236. PMC6813574.
  10. Maehara T, Kaneko N, Perugino CA, Mattoo H, Kers J, Allard-Chamard H, Mahajan VS, Liu H, Murphy SJ, Ghebremichael M, Fox DA, Payne AS, Lafyatis R, Stone JH, Khanna D, Pillai S (2020) Cytotoxic CD4+ T lymphocytes may induce endothelial cell apoptosis in systemic sclerosis. J Clin Invest. 130(5):2451–2464. PMC7190971.
  11. Lee J, Lundgren DK, Mao X, Manfredo-Vieira S, Nunez-Cruz S, Williams EF, Assenmacher CA, Radaelli E, Oh S, Wang B, Ellebrecht CT, Fraietta JA, Milone MC, Payne AS. (2020) Antigen specific B-cell depletion for precision therapy of mucosal pemphigus vulgaris. J Clin Invest., 130:6317-6324. PMC7685721.

Back to top